Disclaimer: This is a simplified summary of a public company filing. See full disclaimer here.

One World Products, Inc.

CIK: 16222442 Annual ReportsLatest: 2025-06-03

10-K / June 3, 2025

Revenue:$4,863
Income:-$3,935,012

10-K / May 23, 2024

Revenue:$7,589
Income:-$3,953,321

10-K / June 3, 2025

Company Summary

Overview

  • Company Name: One World Products, Inc. (formerly One World Pharma, Inc.)
  • Principal Office: 6605 Grand Montecito Pkwy, Suite 100, Las Vegas, Nevada 89149
  • Telephone: (800) 605-3210
  • Employees: 2 full-time employees (as of December 31, 2024)

Business Operations

  • Core Business:

    • Sale of cannabidiol (CBD) products derived from hemp in the United States.
    • The primary product currently sold is Pro-11, a CBD-based product.
    • In early 2024, the company began redesigning packaging and focusing resources on marketing Pro-11.
    • Development of industrial hemp solutions targeting the automotive industry.
      • Developed hemp-based molded containers for automotive part packaging.
      • Received an initial order for 1,400 reusable totes for automotive supply chain applications.
  • Historical Operations:

    • Prior operations involved cannabis cultivation and processing in Colombia.
    • Engaged in cultivation activities in Colombia with a farm in Popayán, which is now being liquidated.
    • As of late 2023 and through 2024, the company's Colombian subsidiary (OWP SAS) filed for reorganization and then liquidation proceedings. OWP SAS has no revenue-producing operations currently.
    • The company focused on completing liquidation, resolving litigation, and asset liquidation.

Financials

  • Revenue: Not specified; currently minimal or none due to liquidation activities.
  • Net Losses:
    • For the year ended December 31, 2024: $3,935,012
    • For the year ended December 31, 2023: $3,953,321
  • Total Accumulated Deficit:
    • As of December 31, 2024: $30,864,698
    • As of December 31, 2023: $26,929,686

Regulatory & Litigation Status

  • Actively sells CBD product in the U.S. compliant with the 2018 Farm Bill (THC not exceeding 0.3%).
  • Colombian subsidiary is under liquidation proceedings—no active revenue from Colombian operations.
  • The company is involved in multiple legal disputes in Colombia, with potential liabilities estimated at approximately $310,000.

Recent Developments

  • Began sales of Pro-11 CBD product in March 2024.
  • Focused on research and development of hemp-based solutions for the automotive industry.
  • Developing and testing hemp-based molded containers, receiving initial order quantity of 1,400 units.

Note: The company is currently in a liquidation phase with minimal ongoing operations and limited financial activity.